FDA Investigator Anissa M Vargas
Anissa M Vargas has inspections in 10 countries as of 12 May 2023. Anissa M Vargas has collaborated with a combined 2353 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
12 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
Germany,
Singapore,
United States of America,
Netherlands,
Switzerland,
France,
Mexico,
China,
Argentina
Co-Investigator(s):
Alice S Tsao,
Amanda L Fyles,
Ana P Pineda Zavaleta,
Anita Narula, PhD,
Anita R Michael,
Anna Lazar,
Anthony A Charity,
Ariel Cruz Figueroa,
Arnold Seo, PhD,
Arsen Karapetyan,
Ashar P Parikh,
Azza Talaat,
Barbara J Rincon,
Brian D Nicholson,
Camerson E Moore,
Carrie A Hughes,
CDR Thomas R Berry, PPh,
Charisse K Green,
Charles M Edwards,
Chiang Syin, PhD,
Christopher R Czajka,
Concepcion Cruz, Jr,
Crystal Monroy,
Dale A Nyberg,
David M Beltran,
Dell S Moller,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Donna F Campbell,
Douglas C Kovacs,
Dr. Carmelo Rosa,
Edwin Melendez,
Eric L Dong, BS,
Eric M Mueller, PharmD,
Erika V Butler,
Felix Maldonado,
George Lunn, PhD,
German Rivera,
Gregson A Joseph,
Hamet Toure, PharmD MPH,
Helen B Ricalde,
Heriberto Negron Rivera,
Ivan E Reyes,
Jacqueline S Warner,
James A Liubicich,
James C Maclaughlin,
Joanne M Schlossin,
Jogy George,
John P Mistler,
Jorge L Guadalupe,
Jose E Melendez, DDC,
Karen E D'orazio,
Katherine Szestypalow,
Kelli F Dobilas,
Kenneth H Williams,
Kent C Faul,
Kevin A Gonzalez,
L Gnnmassimia Massimilla, PharmD,
Larry K Austin,
Lata C Mathew, PhD,
LCDR Michael H Tollon,
Linda K Cline,
Lisa K Capron,
Luella J Rossi,
Luis M Burgos Medero,
Lydia Irosas Marty,
Madushini Dharmasena, PhD,
Margaret M Annes,
Marianela Aponte Cruz,
Marijo B Kambere, PhD,
Marissa S Steinhagen,
Mark R Mcclain,
Matthew A Spataro,
Matthew J Johnson,
Michael E Maselli,
Michael L Casner,
Michele L Obert,
Miguel A Martinez,
Mindy M Chou,
Mra Mcculloughj,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nancy G Schmidt,
Nataniel Phillips Sylvain, PhD,
Nicholas A Violand,
Nicholas L Hunt,
Nicole E Knowlton,
Parul M Patel,
Patricia H Dlugosz,
Paul E Stein,
Paul Mouris,
Perry T Nichols,
Philip F Istafanos, DMV, MS,
Phillip Angart, PhD,
Rafael Nevarez Nieves,
Raquel Gonzalez Rivera,
Reba A Gates,
Robert D Tollefsen,
Robert J Maffei,
Roger F Zabinski,
Russell K Riley,
S Lori Brown, PhD MPH,
Samina S Khan,
Samuel T Walker,
Sarah E Mcmullen,
Shelby N Turner,
Simone E Pitts,
Sony Mathews,
Sripal R Mada, PhD,
Steven M Weinman,
Tamil Arasu, PhD,
Thomas J Arista,
Tiara Nbrown Crosen,
Tracy K Li,
Valentino Fiorella,
Verlinda A Narcisse,
Vioela J Caze,
Vivin George,
Vlada Matusovsky,
Walden H Lee,
William J Leonard,
Winston R Alejo,
Xing Wang, PhD,
Yumi J Hiramine,
Yvesna C Blaise,
Zachary L Stamm,
Zhongren Wu
Anissa M Vargas's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2010 | FDA 483 | Aventis Pharma Manufacturing Pte. Ltd. - Form 483, 2010-07-15 |
March, 2005 | FDA 483 | Professional Disposables International, Inc. - Form 483, 2005-03-03 |
August, 2005 | FDA 483 | Barr Laboratories Inc. - Form 483, 2005-08-25 |
January, 2020 | FDA 483 | Bend Research Inc. - Form 483, 2020-01-24 |
October, 2007 | EIR | Barr Laboratories Inc. - EIR, 2007-10-19 |
August, 2005 | EIR | Barr Laboratories Inc. - EIR, 2005-08-25 |
June, 2011 | FDA 483 | Nouryon Chemicals, S.A. de C.V - Form 483, 2011-06-24 |
January, 2020 | EIR | Bend Research Inc. - EIR, 2020-01-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more